Organic Arsenicals

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 467-475

  Marrs, Timothy C ^a,b,c   Maynard, Robert L ^d  

^a Edentox Associates   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Ethyl, methyl and phenyl dichlorarsine 'Dicks'; Lewisite acute toxicity; Mutagenicity; Organic arsenicals; Subchronic and reproductive toxicity

Indexed keywords

EID: 84883787991     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch23     Document Type: Chapter

References (44)

1. Aposhian HV (1983). DMSA and DMPS-water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol, 23, 193-215.
2. Aposhian HV, Carter CD, Hoover TD et al. (1984). DMSA, DMPS and DMPA-as arsenic antidotes, Fund Appl Toxicol, 4, S58-S70.
3. BatemanN and Marrs TC (1999). Antidotal studies. In: General and Applied Toxicology. (B Ballantyne,TC Marrs and T Syversen, eds), pp. 425-435. London, UK: MacMillan Reference Limited.
4. Bucci TJ,ParkerRM,Dacre JC et al. (1993). Dominant lethal study of lewisite in male rats, AD-A290671. Fort Detrick, Frederick, MD, USA: US Army Medical Research and Materiel Command.
5. Dill K, Adams ER, O'Connor RJ et al. (1987). 2D NMR studies of the phenyldichloroarsine British anti-lewisite adduct. Magn Reson Chem, 25, 1074-1077.
6. Ehrlich P (1909). Über den jetzigen Stand der Chemotherapie. Ber Deutsch Chem Ges, 42, 17.
7. Emanuelli T, Rocha JBT, Pereira ME et al. (1998). δ-Aminolevulinate dehydratase inhibition by 2,3-dimercaptopropanol is mediated by chelation of zinc from a site involved in maintaining cysteinyl residues in a reduced state. Pharmacol Toxicol, 83, 95-103.
8. Fournier L, Thomas G, Garnier R et al. (1988). 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med Toxicol, 3, 499-504.
9. Friedenwald JS and Hughes WF (1948). The Effects of Toxic Chemical Agents on the Eyes and their Treatment, Advances in Military Medicine, Volume II. Boston, MA, USA: Little Brown and Company.
10. Goldman M and Dacre JC (1989). Lewisite: its chemistry, toxicology and biological effects. RevEnviron Contam Toxicol, 110, 75-115.
11. Graziano JH (1986). Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol, 1, 155-162.
12. Hackett PL, Sasser LB, Rommereim RL et al. (1987). Teratology studies on lewisite and sulphur mustard agents: effects of lewisite in rats and rabbits, ADA198423, Fort Detrick, Frederick, MD, USA: US Army Research and Development Command.
13. Hackett PL, Sasser LB, Rommereim RL et al. (1992). Developmental toxicity of lewisite in rats and rabbits. Toxicologist, 12, 198.
14. Hunter D (1978). The Diseases of Ocuupations, 6th Edition, pp. 368-369. London, UK: Hodder and Stoughton.
15. Inns RH and Rice P (1993). Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits. Human Exp Toxicol, 12, 241-246.
16. Inns RH, Bright JE and Marrs TC (1988). Comparative acute systemic toxicity of sodium arsenite and dichloro(2-chlorovinyl)arsine in rabbits. Toxicology, 51, 213-222.
17. Inns RH, Rice P, Bright JE et al. (1990). Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits. Human and Exp Toxicol, 9, 215-220.
18. Ireland MW (1926). Medical Aspects of Chemical Warfare. The Medical Department of the US Army in World War 1, Volume XIV. Washington, DC, USA: Government Printing Office.
19. Jostes RF, Rausch RJ and Sasser LB (1989a). Toxicology studies on lewisite and sulphur mustard agents: mutagenicity study of sulphur mustard (HD) in Chinese hamster ovary cells. Report AD-A216449. Fort Detrick Frederick, MD, USA: US Army Research and Development Command.
20. Jostes RF, Rausch RJ, MillerBM et al. (1989b). Genotoxicity of lewisite in Chinese hamster ovary cells. Toxicologist, 9, 232.
21. JSP 312 (1972). Medical Manual of Defence against Chemical Agents. London, UK: HMSO.
22. King JR, Peters BP and Monteiro-Riviere NA (1994). Laminin in the cutaneous basement membrane as a potential target in lewisite vesication. Toxicol Appl Pharmacol, 126, 164-173.
23. Klaassen CD (2002). Heavy metals and heavy metal antagonists. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th Edition (J Hardman and LE Liford, eds), pp. 1861-1875. New York, NY, USA: McGraw-Hill.
24. Martindale (1993). The Extra Pharmacopoeia, 30th Edition (JEF Reynolds, ed.), London, UK: Pharmaceutical Press.
25. Maynard RL (1989). A review of chemical warfare agents, CDE Technical Paper, 2nd Edition. Porton Down, Salisbury, UK: CDE.
26. Modell W, Gould H and Cattell M (1946). Clinical uses of 2,3-dimercapto-propanol (BAL). IV Pharmacologic observations on BAL by intramuscular injection in man. J Clin Invest, 25, 480-487.
27. Moore DF, O'Callaghan CA, Berlyne G et al. (1994). Acute arsenic poisoning after treatment with 2,3-dimercaptopropanesulphonate (DMOS). J Neurol Neurosurg Psychiat, 57, 1133-1135.
28. Ord MA and Stocken LA (2000). A contribition of chemical defence inWorldWar II. Trends Biochem Sci, 25, 253-256.
29. Prentiss AM (1937). Chemicals in War. New York, NY, USA: McGraw-Hill Book Company.
30. Peters R (1948). Development and theoretical significance of British Anti-Lewisite (BAL). Br Med Bull, 5, 313-318.
31. Peters R (1953). Significance of biochemical lesions in the pyruvate oxidase system. Br Med Bull, 9, 116-119.
32. Peters RA, Stocken LA and Thompson RHS (1945). British anti-lewisite (BAL). Nature, 156, 616-691.
33. Platteborze PL (2005). The transcriptional effects of the vesicants lewisite and sulphur mustard on human epidermal keratinocytes. Toxicol Mech Meth, 15, 185-192.
34. Rittey DAW (1949). Treatment of accidental arsenical poisoning with dimercaprol. Lancet, 2, 719.
35. Sasser LB, Cushing JA, Mellick PW et al. (1996). Subchronic toxicity evaluation of lewisite in rats. J Toxicol Environ Health, 47, 321-334.
36. Sasser LB, Cushing JA, Lindenmeier CW et al. (1999). Two-generation study of lewisite in rats. J Appl Toxicol, 19, 229-235.
37. Stewart CE and Sullivan JB (1992). Military munitions and antipersonnel agents. In: Hazardous Materials Toxicology (JB Sullivan and GR Krieger, eds), pp. 986-1026. Baltimore, MD, USA:Williams and Wilkins.
38. Stewart DL, Sass EJ, FritzLKet al. (1989). Toxicology studies on Lewisite and sulphur mustard agents: mutagenicity of Lewisite in the salmonella histidine reversion assay, Report AD-A213146. Fort Detrick, Frederick, MD, USA: US Army Medical Research and Development Command.
39. Stocken LA and Thompson RHS (1946). British antilewisite, arsenic and thiol excretion in animals after treatment of lewisite burns. Biochem J, 40, 548-554.
40. Sulzberger MB, Boer RL and Kanof A (1946). Clinical uses of 2,3-dimercaptopropanol (BAL) III. Studies on the toxicity of BAL on percutaneous and parenteral administrations. J Clin Invest, 25, 474-479.
41. US Army (1974). Chemical Data Sheets, Volume I, Report EO-SR-74001, pp. 65-72. Edgewood Arsenal, MD, USA: Development and Engineering Directorate.
42. Vedder EB (1926). The Medical Aspects of Chemical Warfare. Baltimore, MD, USA: Williams and Wilkins.
43. Vilensky JA and Redman K (2003). British antilewisite (dimercaprol): an amazing history. Ann Emerg Med, 41, 378-383.
44. Wieland OH (1983). The mammalian pyruvate dehydrogenase complex: structure and regulation. Rev Physiol Biochem Pharmacol, 96, 123-170.